EUVIMEDEUVIMED entdecken
Klinische StudieVergleichsstudieKontrollierte klinische Studie

Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl

E Martignoni, G Bono, F Blandini, E Sinforiani, P Merlo, G Nappi

Journal of Neural Transmission - Parkinson's Disease and Dementia Section · 1991

DOI: 10.1007/bf02251133 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Neural Transmission - Parkinson's Disease and Dementia Section, 1991. Verfasst von E Martignoni und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology III, University of Pavia, Italy. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An impairment of the monoaminergic systems has frequently been reported for Alzheimer's disease (AD) as well as an overactivity of cerebral monoamineoxidase B (MAO-B). L-deprenyl (LD), a selective and irreversible MAO-B inhibitor, has recently been proposed for the treatment of AD. The cerebrospinal fluid (CSF) levels of norepinephrine (NE), epinephrine (E), dopamine (DA), 3-methoxy-4-hydroxyphenylglycol (MHPG), 5-hydroxyindoleacetic acid (5-HIAA), and homovanillic acid (HVA) were studied in 14 patients suffering from dementia of Alzheimer type (DAT) and in 14 controls. A three-month double-blind study comparing LD with placebo was carried out, in the DAT group, and the influence of the treatment on neurotransmitter levels and cognitive performance was evaluated. The basal study revealed a significant reduction in CSF NE and HVA levels in DAT patients when compared with controls; the treatment with LD determined a significant decrease in HVA levels only and, as to neuropsychological investigation, a global amelioration of cognitive performances.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgedAlzheimer DiseaseBiogenic MonoaminesCognitionDopamineDouble-Blind MethodEpinephrineFemaleHomovanillic AcidHumansHydroxyindoleacetic AcidMaleMethoxyhydroxyphenylglycolMiddle AgedNeuropsychological TestsNorepinephrinePsychiatric Status Rating ScalesPsychological TestsSelegiline

Substanzen

Biogenic MonoaminesSelegilineMethoxyhydroxyphenylglycolHydroxyindoleacetic AcidDopamineNorepinephrineHomovanillic AcidEpinephrine

Autor:innen und Institutionen

  • Department of Neurology III, University of Pavia, Italy.

Zitieren

APA

Martignoni, E., Bono, G., Blandini, F., Sinforiani, E., Merlo, P., & Nappi, G. (1991). Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl. Journal of Neural Transmission - Parkinson's Disease and Dementia Section. https://doi.org/10.1007/bf02251133

Vancouver

Martignoni E, Bono G, Blandini F, Sinforiani E, Merlo P, Nappi G. Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl. Journal of Neural Transmission - Parkinson's Disease and Dementia Section. 1991. doi:10.1007/bf02251133

BibTeX
@article{Martignoni1991,
  author = {Martignoni, E and Bono, G and Blandini, F and Sinforiani, E and Merlo, P and Nappi, G},
  title = {Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl},
  journal = {Journal of Neural Transmission - Parkinson's Disease and Dementia Section},
  year = {1991},
  doi = {10.1007/bf02251133}
}
Kostenlos starten →